13 employees
Cardiosense is a digital biomarker platform that provides multi-sensor devices and proprietary algorithms to detect early signs of diseases.
2020
$15M
from 4 investors over 4 rounds
Cardiosense raised $15M on December 8, 2022
Investors: UnityPoint Health Ventures, Portal Innovations, LLC, Laerdal Million Lives Fund and Broadview Ventures Inc